SCHEMBL27645404

SCHEMBL27645404

O=C1C=CC(=O)C(OCl)=C1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERBB2 P04626 1/20 0.58
TDP1 Q9NUW8 3/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 3/20 0.46
KMT2A Q03164 3/20 0.46
ALDH1A1 P00352 2/20 0.46
RECQL P46063 2/20 0.46
HPGD P15428 1/20 0.46
ALOX12 P18054 1/20 0.46
MAOA P21397 5/20 0.44
MAOB P27338 5/20 0.44
MAPK1 P28482 3/20 0.35
BCHE P06276 1/20 0.35
POLB P06746 1/20 0.35
ACHE P22303 1/20 0.35
APEX1 P27695 1/20 0.35
CASP1 P29466 1/20 0.35
BLM P54132 1/20 0.35
MDM2 Q00987 1/20 0.35
DHODH Q02127 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL49620 0.74 ERBB2 (1.00) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL28861798 0.74 ERBB2 (0.58) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL1067701 0.74 ERBB2 (0.58) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL20087538 0.72 MAOA (0.57) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL28113764 0.70 ERBB2 (0.91) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL899103 0.70 ERBB2 (0.54) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL8582510 0.69 ERBB2 (0.58) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL1524084 0.69 ERBB2 (0.58) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL3155612 0.69 MAOA (0.53) ERBB2TDP1MEN1MAPTKMT2A
SCHEMBL10333756 0.69 ERBB2 (0.52) ERBB2TDP1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109923106-A Toll sample receptor modulator compounds 吉利德科学公司 2019-06-21 CN disclosed
CN-107709315-A The inhibitor of bruton's tyrosine kinase 药品循环有限责任公司 2018-02-16 CN disclosed
CN-107530347-A The co-crystal thereof of bruton's tyrosine kinase inhibitor 药品循环有限责任公司 2018-01-02 CN disclosed
CN-107530346-A The solvation form of bruton's tyrosine kinase inhibitor 药品循环有限责任公司 2018-01-02 CN disclosed
CN-106661039-A TYK2 inhibitors and uses thereof 林伯士拉克许米公司 2017-05-10 CN disclosed
CN-104853754-A Azaindole derivatives as jak3 inhibitors PRINCIPIA BIOPHARMA INC 2015-08-19 CN disclosed
CN-103097353-B Immunomodulator and anti-inflammatory compound INCOZEN THERAPEUTICS PVT LTD 2015-03-04 CN disclosed
CN-103097353-A Novel immunomodulator and anti-inflammatory compounds INCOZEN THERAPEUTICS PVT LTD 2013-05-08 CN disclosed
CN-102665711-A Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents SIGMA TAU IND FARMACEUTI 2012-09-12 CN disclosed
CN-101589025-B Aminonicotinic acid and isonicotinic acid derivatives as dihydrolactate dehydrogenase (DHODH) inhibitors ALMIRALL LAB 2012-05-30 CN disclosed
CN-102256969-A Compounds that modulate intracellular calcium CALCIMEDICA INC 2011-11-23 CN disclosed
CN-101589025-A Aminonicotinic acid and isonicotinic acid derivatives as dihydrolactate dehydrogenase (DHODH) inhibitors ALMIRALL LAB (ES) 2009-11-25 CN disclosed
CN-101421269-A Inhibitors of tyrosine kinases and uses thereof PHARMACYCLICS INC (US) 2009-04-29 CN disclosed
CN-1980902-A Method for preparing 5-'4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h'1,2,4!triazin-2-yl!-benzamide derivatives by deprotecting the hydroxyl-protected precursers PFIZER (US) 2007-06-13 CN disclosed
CN-1886157-A Pharmaceutical combinations NOVARTIS AG (CH) 2006-12-27 CN disclosed